The miRNA–drug resistance connection: a new era of personalized medicine using noncoding RNA begins
Author:
Affiliation:
1. Center for Cancer Research, National Cancer Institute, National Institutes of Health,37 Convent Drive, Bethesda, MD 20892, USA.
Publisher
Future Medicine Ltd
Subject
Pharmacology,Genetics,Molecular Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/pgs.12.121
Reference40 articles.
1. A vision for the future of genomics research
2. Initial impact of the sequencing of the human genome
3. An Extensive Class of Small RNAs in Caenorhabditis elegans
4. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
5. Pharmacogenomics of microRNA: a miRSNP towards individualized therapy
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Meta‐analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer;Cancer Reports;2023-11-07
2. GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning;Briefings in Bioinformatics;2023-07
3. MiR‑221 and miR‑222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3;Experimental and Therapeutic Medicine;2023-02-07
4. The Roles of microRNAs in Cancer Multidrug Resistance;Cancers;2022-02-21
5. Current paradigms in epigenetic anticancer therapeutics and future challenges;Seminars in Cancer Biology;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3